Lineage Cell Therapeutics... (LCTX)

AMEX: LCTX · Real-Time Price · USD

0.48

-0.02 (-3.81%)

At close: May 01, 2025, 3:59 PM

0.50

4.15%

Pre-market: May 02, 2025, 09:21 AM EDT

Lineage Cell Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	9.5M	8.95M	14.7M	3.9M	773K	1.48M	1.42M	1.79M	2.25M
Cost of Revenue	334K	671K	728K	1.43M	385K	412K	302K	168K	358K
Gross Profit	9.16M	8.27M	13.97M	2.47M	388K	1.07M	1.11M	1.62M	1.89M
Operating Income	-21.48M	-24.73M	-22.52M	-49.21M	-26.45M	-38.88M	-41.8M	-38.9M	-58.97M
Interest Income	1.72M	1.63M	829K	2K	1.04M	1.69M	n/a	n/a	n/a
Pretax Income	-18.58M	-23.28M	-25.81M	-43.27M	-21.92M	-19.23M	-47.13M	-23.29M	18.62M
Net Income	-18.61M	-21.49M	-26.35M	-38.56M	-20.68M	-11.83M	-45.99M	-19.98M	33.57M
Selling & General & Admin	18.17M	17.3M	22.51M	18.21M	15.57M	24.03M	24.73M	19.92M	28.43M
Research & Development	12.47M	15.71M	13.99M	33.91M	12.32M	17.95M	20.95M	24.02M	36.11M
Other Expenses	n/a	n/a	-2.15M	-445K	-1.05M	-2.04M	-1.31M	1.45M	-403K
Operating Expenses	30.64M	33.01M	36.49M	51.68M	26.84M	39.94M	42.11M	42.28M	60.86M
Interest Expense	n/a	n/a	5.18M	n/a	n/a	1.69M	10.87M	692K	747K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	30.98M	33.68M	37.22M	53.11M	27.22M	40.35M	42.41M	42.45M	61.22M
Income Tax Expense	27K	-1.8M	541K	-4.71M	-1.24M	-7.41M	-346K	-37.29M	-175.95M
Shares Outstanding (Basic)	200.19M	172.66M	169.79M	164.5M	150.04M	145.53M	126.9M	114.48M	97.32M
Shares Outstanding (Diluted)	200.19M	172.66M	169.79M	164.5M	150.04M	145.53M	126.9M	114.48M	99.55M
EPS (Basic)	-0.09	-0.12	-0.16	-0.23	-0.14	-0.08	-0.36	-0.17	0.35
EPS (Diluted)	-0.09	-0.12	-0.16	-0.23	-0.14	-0.08	-0.36	-0.17	0.34
EBITDA	-21.48M	-24.04M	-21.79M	-48.34M	-24.41M	-38.88M	-37.72M	-37.36M	-54.21M
EBIT	-21.48M	-24.73M	-22.52M	-49.21M	-26.45M	-38.88M	-40.99M	-40.66M	-58.97M
Depreciation & Amortization	n/a	692K	727K	887K	2.11M	3.13M	3.27M	3.3M	4.76M